1/10/12 – Drugs Recalled After Possible Mix-up

By Joe Messa

Jan 10

Drugs Recalled After Possible Mix-up

January 10, 2012 – The FDA is advising patients to inspect pills produced by Endo Pharmaceuticals after the drugmaker Novartis announced that it will recall 1,645 lots of over the counter medications, including bottles of Excedrin, NoDoz, Bufferin and Gas-X.  The company says the bottles could contain stray pills from other medicines, or chipped or broken tablets.  Customers who take the recalled pills could be at risk for taking pills they are allergic to which may cause serious or deadly allergic reactions.  In addition, patients could unknowingly be mixing drugs that may be dangerous when mixed with their other medications resulting in serious injury or death.

Last month, Novartis announced that it would temporarily suspend production at its Lincoln, Neb., plant, where the recalled drugs were manufactured, for “maintenance and other improvement activities.”

The Philadelphia drug injury attorneys at Messa & Associates have handled dozens of cases involving serious injuries and death related to the use of defective drugsOur attorneys have successfully pursued litigation and obtained verdicts and settlements for victims of suffering from these injuries.  If you or a loved one has suffered serious injury or death as a result of this or any other recalled product, please contact us at 1-877-MessaLaw.


About the Author

Joseph L. Messa, Jr. is the founding partner of Messa & Associates, P.C. He is an AV-rated attorney (highest rating available), listed in the Bar Register of Preeminent Lawyers. Read More